Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.
Détails
ID Serval
serval:BIB_CC8D1F6C6D1E
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.
Périodique
Frontiers in oncology
ISSN
2234-943X (Print)
ISSN-L
2234-943X
Statut éditorial
Publié
Date de publication
2022
Peer-reviewed
Oui
Volume
12
Pages
902929
Langue
anglais
Notes
Publication types: Published Erratum
Publication Status: epublish
Publication Status: epublish
Mots-clé
Cancer Research, Oncology, TTFields, Tumor Treating Fields, efficacy and safety, elderly patients, newly diagnosed glioblastoma, phase 3 clinical trial, quality-of-life, temozolomide
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/03/2023 9:45
Dernière modification de la notice
28/11/2023 8:11
Données d'usage
